의약품 관련 법령
A Risk-Based Approach to Monitoring of Clinical Investigations; Questions and Answers; Guidance for Industry
| 작성자 | 관리자 | ||
|---|---|---|---|
| 작성일 | 2019-03-14 | 조회수 | 1,353 |
| 국가정보 | 북 아메리카>미국 | ||
| 출처 | FDA | ||
| 원문 | https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM633316.pdf | ||
| 첨부파일 | |||
UCM633316.pdf(117.55KB)A Risk-Based Approach to Monitoring of Clinical Investigations; Questions and Answers; Guidance for Industry
- 이전글 Cancer Clinical Trial Eligibility Criteria: Patients with HIV, Hepatitis B Virus, or Hepatitis C Virus Infections; Guidance for Industry
- 다음글 Labeling for Human Pre-ion Drug and Biological Products Approved Under the Accelerated Approval Regulatory Pathway
